ニューメキシコにおける卵巣がんの臨床試験
ニューメキシコ内の拠点で、卵巣がんに関する16件の研究が参加者を募集しています。
ニューメキシコ内の都市
公式研究テキスト（英語）
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- University of New Mexico Cancer Center, Albuquerque
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07001748Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- University of New Mexico Cancer Center, Albuquerque
被験者募集中第2相
全年齢 · 全性別 · 2026/10/05更新 · NCT05564377A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Optimum Clinical Research Group /ID# 274583, Albuquerque
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT06890338Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Albuquerque
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/09/23更新 · NCT05489211A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Optimum Clinical Research Group, Albuquerque
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer
- University of New Mexico Cancer Center, Albuquerque
被験者募集中観察研究
18歳以上 · 女性 · 2026/09/18更新 · NCT03943316Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Unm Comprehensive Cancer Center, Albuquerque
被験者募集中第3相
18歳以上 · 女性 · 2026/09/15更新 · NCT07214779A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Albuquerque
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT05123482A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- University of New Mexico Comprehensive Cancer Center ( Site 0055), Albuquerque
被験者募集中第3相
18歳以上 · 女性 · 2026/09/03更新 · NCT06824467A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- University of New Mexico Cancer Center, Albuquerque
- Presbyterian Rust Medical Center/Jorgensen Cancer Center, Rio Rancho
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of New Mexico Cancer Center, Albuquerque
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314Clinical Pre-screening Protocol for Ovarian Cancer
- University of New Mexico Comprehensive Cancer, Albuquerque
被験者募集中観察研究
18歳以上 · 女性 · 2026/07/30更新 · NCT03877796Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 292, Albuquerque
被験者募集中第2相
18歳以上 · 女性 · 2026/07/16更新 · NCT06906341Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- University of New Mexico Comprehensive Cancer Center, Albuquerque
被験者募集中第3相
18歳以上 · 女性 · 2026/04/16更新 · NCT05659381SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Albuquerque
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。